MARKET ACCESS STRATEGY + IMPLEMENTATION = COMMERCIAL IMPACT

ASIA-PACIFIC AND EMERGING MARKETS

OBJECTIVE

To help our client prepare its access planning for a new targeted cancer therapy in Argentina, Australia, China, Hong Kong, Korea, Mexico, Russia, Taiwan and Turkey by identifying a) how each P&R system has treated existing therapies in the same class and b) how each P&R system will likely respond to a new entrant to that class.

​

PROJECT APPROACH

We took a pragmatic approach, based on a limited budget from the client. First, we answered as many of our research questions through secondary research. Only after that, did we conduct primary research with KOLs and payers in order to fill the remaining gaps.

 

As a result, in Australia we mapped the landscape through secondary research only, while in Argentina and Russia we conducted five stakeholder discussions. In China we conducted eight discussions so we could gauge the landscape in second-tier provinces and cities, as well as the obvious Tier 1 targets.

​

OUTPUTS

We provided the client with detailed access landscapes for each of the ten markets, as well as a cross-market executive summary for senior management. The project outputs then fed into other commercial strategy work-streams the client had running.